The global roxatidine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Roxatidine is a special H2-receptor antagonist, highly targeted for reflux esophagitis, benign gastric ulcer, duodenal ulcer, and prophylaxis of recurrent ulcers. The roxatidine market is growing at a steady rate and with the increasing adoption of strategies by […]
